@jhrheumatology data on ESRD in Lupus Nephritis, Dr. Michelle Petri. #ACR21 Debate ▶️ 20% risk of renal failure in 20 years is way too high ▶️ C3 strongest predictor, dsDNA also seen ⭐️⬇️ complement, ⬆️dsDNA in lupus nephritis suggests Belimumab is good agent for LN @Rheumnow https://t.co/ewLAxMgTT0